Exploration of New Pyrazole–Hydrazone–Benzenesulfonamide Conjugates as Potent Mycobacterial Carbonic Anhydrase Inhibitors: Design, Synthesis, and Biological Evaluation
ChemMedChem · 28.11.2025 · 20 (23)
DOI: 10.1002/cmdc.202500633 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 16.10.2025. Verfasst von Pardeep Kumar und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Telangana, Hyderabad, 500037, India. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Mycobacterium tuberculosis, Pyrazoles, Sulfonamides. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Abstract (Originalsprache)
The growing threat of multidrug‐resistant tuberculosis highlights the need for new agents with alternative mechanisms of action. Herein, a series of pyrazole‐sulfonamide derivatives are synthesized and evaluated for inhibition of Mycobacterium tuberculosis β ‐carbonic anhydrases (MtCA 1 and MtCA 3). N‐substituted analogues ( 6a–6i ) are inactive, while compounds bearing a free sulfonamide group (SO 2 NH 2 ) ( 5a–5s ) exhibit potent inhibitory activity, with K i values of 0.2154–0.7542 µM for MtCA 1 and 0.0548–0.3241 µM for MtCA 3. Molecular docking studies support their binding interactions and selectivity. Antitubercular screening of all synthesized compounds reveals minimum inhibitory concentration (MIC) values in the range of 4–128 µg mL −1 . Among them, compound 5p emerges as the most potent derivative, with a K i of 0.07 µM against MtCA 3 and an MIC of 8 µg mL −1 , outperforming the reference inhibitor acetazolamide. It exhibits no cytotoxicity in THP‐1 cells, showing no toxicity against human cell lines, and demonstrates a favorable selectivity index. Furthermore, compound 5p retains activity against rifampicin‐resistant M. tuberculosis . In silico ADMET predictions indicate acceptable pharmacokinetic and safety profiles. These findings suggest that compound 5p is a promising lead for the development of novel antitubercular agents, potentially acting through MtCA inhibition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Telangana, Hyderabad, 500037, India.
- Department of Biological Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Telangana, Hyderabad, 500037, India.
- Neurofarba Department, University of Florence, Section of Pharmaceutical Sciences, Via Ugo Schiff 6, Sesto Fiorentino, 50019, Florence, Italy.
- Department NEUROFARBA-Pharmaceutical and nutraceutical section Laboratory of Molecular Modeling Cheminformatics & QSAR, University of Florence, Via Ugo Schiff 6, 50019, Sesto Fiorentino (Florence), Italy.
ORCID-Profile: Anuradha Singampalli, Srinivas Nanduri, Nitin Pal Kalia, Niccolò Paoletti, Alessandro Bonardi, Paola Gratteri, Claudiu T Supuran, Venkata Madhavi Yaddanapudi
Zitieren
APA
Kumar, P., Singampalli, A., Bandela, R., Bellapukonda, S. M., Korra, L. N., Kodi, R., Ghosh, S., Dalal, A., Agnivesh, P. K., Devi, A., Nanduri, S., Kalia, N. P., Paoletti, N., Bonardi, A., Gratteri, P., Supuran, C. T., & Yaddanapudi, V. M. (2025). Exploration of New Pyrazole–Hydrazone–Benzenesulfonamide Conjugates as Potent Mycobacterial Carbonic Anhydrase Inhibitors: Design, Synthesis, and Biological Evaluation. ChemMedChem, 20(23). https://doi.org/10.1002/cmdc.202500633
Vancouver
Kumar P, Singampalli A, Bandela R, Bellapukonda SM, Korra LN, Kodi R, et al. Exploration of New Pyrazole–Hydrazone–Benzenesulfonamide Conjugates as Potent Mycobacterial Carbonic Anhydrase Inhibitors: Design, Synthesis, and Biological Evaluation. ChemMedChem. 2025;20(23). doi:10.1002/cmdc.202500633
BibTeX
@article{Kumar2025,
author = {Kumar, Pardeep and Singampalli, Anuradha and Bandela, Rani and Bellapukonda, Sri Mounika and Korra, Laxma Naik and Kodi, Ramakrishna and Ghosh, Subhendu and Dalal, Aman and Agnivesh, Puja Kumari and Devi, Ankita and Nanduri, Srinivas and Kalia, Nitin Pal and Paoletti, Niccolò and Bonardi, Alessandro and Gratteri, Paola and Supuran, Claudiu T and Yaddanapudi, Venkata Madhavi},
title = {Exploration of New Pyrazole–Hydrazone–Benzenesulfonamide Conjugates as Potent Mycobacterial Carbonic Anhydrase Inhibitors: Design, Synthesis, and Biological Evaluation},
journal = {ChemMedChem},
year = {2025},
volume = {20},
number = {23},
doi = {10.1002/cmdc.202500633}
}
EUVIMED